GPT and Alzheimer disease: These changes were corrected upon TEO intervention, as evidenced by ALT (10%, 6.367 ± 1.484; 5%, 11.28 ± 1.538) and TG (10%, 0.197 ± 0.009; 5%, 0.15 ± 0.015) levels reaching a significant difference from the AD group.